Dalteparin Injection and Guggul: Interaction Details
- Dalteparin Injection
- Fragmin
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Dalteparin Injection and Guggul interaction:
Dalteparin Injection
- Fragmin
Guggul
We don't have a drug information page for Guggul yet. Have a question about Guggul? Ask a pharmacist, free →
What Happens When You Take Dalteparin Injection With Guggul
What can happen when they are taken together (rated Moderate)
Increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
In theory, combining guggul with low molecular weight heparins could heighten the likelihood of bleeding. In human subjects, guggul has been shown to enhance fibrinolytic activity and to lessen hypercoagulability through a lowering of serum lipids.12
In addition, aggregation was inhibited by guggul in vitro.3 of guggul and low molecular weight heparins therefore warrants caution.
The Dalteparin Injection and Guggul Interaction, Explained
Dalteparin (Fragmin) is a shot that helps prevent dangerous clots. Guggul is an herbal supplement often used for cholesterol. Some studies suggest guggul may also make blood a little slower to clot, partly by keeping (tiny clotting cells) from sticking together.
Taken together, there is a possible added risk of bleeding. This concern is mostly theoretical, based on lab and limited human data, so there's no need to panic. Just let your pharmacist or doctor know you use guggul. Your care team can keep an eye on you and help you use both safely.
Dalteparin + guggul: possible bleeding risk ().
- Mechanism: Guggul (Commiphora mukul) increased fibrinolytic activity and reduced hypercoagulability (attributed to lipid lowering) in humans, and inhibited aggregation in vitro. These effects may add to the anti-Xa effect of dalteparin. No PK interaction is described.
- Severity/onset: Moderate; delayed onset.
- Evidence: Theoretical. No clinical reports of bleeding with this combination; magnitude unknown.
- Management: Use with caution if coadministered. Monitor for signs and symptoms of excessive bleeding (bruising, mucosal or bleeding, hematuria). Ask patients about herbal supplement use.
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Dalteparin Injection and Guggul Interact
The likely mechanism
Increased fibrinolytic activity, of aggregation, and reduced hypercoagulability as a result of reduced serum lipids
How to Manage the Dalteparin Injection and Guggul Interaction
The main step here is awareness and watching for bleeding. If you use both, your care team may monitor you more closely.
- Keep taking your medicines as prescribed, and do not start or stop guggul without talking to your pharmacist or doctor first.
- Tell your prescriber and pharmacist that you take guggul.
- Watch for unusual bruising, bleeding gums, nosebleeds that won't stop, blood in urine, or black or bloody stools, and report them promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Dalteparin Injection or Guggul need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease
A controlled trial (n=40) demonstrated that, in healthy individuals, fraction A of gum guggul (0.5 grams twice a day) raised serum fibrinolytic activity by 22% within 24 hours and by 40% after one month. Among patients with coronary artery disease, activity rose by 29.8% after 30 days.
These effects were maintained for as long as guggul was given and tended to revert to baseline once it was stopped (duration not given). Additional studies have described prothrombin times returning to baseline 3 weeks after guggul was discontinued.1
-
Report 2 · Study title
Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis
A controlled trial using crude guggul found that coagulation time increased in 9 patients, 6 of whom were obese, 2 of whom had ischemic heart disease, and 1 of whom had cerebral thrombosis. This effect was believed to be directly linked to the reduction in circulating blood lipids, which prevented hypercoagulability. Serum turbidity was also shown to decline to nearly normal levels.2
Dalteparin Injection and Guggul: Common Questions
How serious is the Dalteparin Injection and Guggul interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Dalteparin Injection and Guggul interaction managed?
The main step here is awareness and watching for bleeding. If you use both, your care team may monitor you more closely. Keep taking your medicines as prescribed, and do not start or stop guggul without talking to your pharmacist or doctor first. Tell your prescriber and pharmacist that you take guggul. Watch for unusual bruising, bleeding gums, nosebleeds that won't stop, blood in urine, or black… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Dalteparin Injection and Guggul Interaction
Ask in your own words about taking Dalteparin Injection and Guggul together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Bordia A & Chuttani SK: Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease. Indian J Med Res 1979; 70(Dec):992-996.
- Tripathi SN, Shastri VVS, & Scharya GVS: Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis. J Res Indian 1968; 2:140-154.
- Mester L, Mester M, & Nityanand S: Inhibition of platelet aggregation by "guggulu" steroids. Planta Med 1979; 37(4):367-369. PubMed
Other Serious Interactions of Dalteparin Injection and Guggul
Also serious with Dalteparin Injection
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.